FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212165740> ?p ?o ?g. }

• W3212165740 endingPage "139" @default.
• W3212165740 startingPage "128" @default.
• W3212165740 abstract "Duloxetine (DLX) is a dual serotonin and norepinephrine reuptake inhibitor, widely used for the treatment of major depressive disorder. Although DLX has shown good efficacy and safety, serious adverse effects (e.g., liver injury) have been reported. The mechanisms associated with DLX-induced toxicity remain elusive. Drug metabolism plays critical roles in drug safety and efficacy. However, the metabolic profile of DLX in mice is not available, although mice serve as commonly used animal models for mechanistic studies of drug-induced adverse effects. Our study revealed 39 DLX metabolites in human/mouse liver microsomes and mice. Of note, 13 metabolites are novel, including five N-acetyl cysteine adducts and one reduced glutathione (GSH) adduct associated with DLX. Additionally, the species differences of certain metabolites were observed between human and mouse liver microsomes. CYP1A2 and CYP2D6 are primary enzymes responsible for the formation of DLX metabolites in liver microsomes, including DLX-GSH adducts. In summary, a total of 39 DLX metabolites were identified, and species differences were noticed in vitro. The roles of CYP450s in DLX metabolite formation were also verified using human recombinant cytochrome P450 (P450) enzymes and corresponding chemical inhibitors. Further studies are warranted to address the exact role of DLX metabolism in its adverse effects in vitro (e.g., human primary hepatocytes) and in vivo (e.g., Cyp1a2-null mice). SIGNIFICANCE STATEMENT: This current study systematically investigated Duloxetine (DLX) metabolism and bioactivation in liver microsomes and mice. This study provided a global view of DLX metabolism and bioactivation in liver microsomes and mice, which are very valuable to further elucidate the mechanistic study of DLX-related adverse effects and drug-drug interaction from metabolic aspects." @default.
• W3212165740 created "2021-11-22" @default.
• W3212165740 creator A5016526298 @default.
• W3212165740 creator A5017978744 @default.
• W3212165740 creator A5018244700 @default.
• W3212165740 creator A5020229055 @default.
• W3212165740 creator A5035565807 @default.
• W3212165740 creator A5044949766 @default.
• W3212165740 creator A5046280891 @default.
• W3212165740 creator A5050632280 @default.
• W3212165740 creator A5056114856 @default.
• W3212165740 creator A5056914488 @default.
• W3212165740 creator A5073265550 @default.
• W3212165740 creator A5074564751 @default.
• W3212165740 creator A5078548892 @default.
• W3212165740 creator A5079261300 @default.
• W3212165740 creator A5081844561 @default.
• W3212165740 creator A5090813047 @default.
• W3212165740 date "2021-11-16" @default.
• W3212165740 modified "2023-10-07" @default.
• W3212165740 title "Metabolism of a Selective Serotonin and Norepinephrine Reuptake Inhibitor Duloxetine in Liver Microsomes and Mice" @default.
• W3212165740 cites W1700007903 @default.
• W3212165740 cites W1971393265 @default.
• W3212165740 cites W1975175626 @default.
• W3212165740 cites W1975290431 @default.
• W3212165740 cites W1984615841 @default.
• W3212165740 cites W1986447382 @default.
• W3212165740 cites W1991118644 @default.
• W3212165740 cites W1997317586 @default.
• W3212165740 cites W1997897040 @default.
• W3212165740 cites W2002378649 @default.
• W3212165740 cites W2003924139 @default.
• W3212165740 cites W2006129012 @default.
• W3212165740 cites W2016577926 @default.
• W3212165740 cites W2017636709 @default.
• W3212165740 cites W2018425549 @default.
• W3212165740 cites W2022053645 @default.
• W3212165740 cites W2043595892 @default.
• W3212165740 cites W2061271938 @default.
• W3212165740 cites W2079421115 @default.
• W3212165740 cites W2083224028 @default.
• W3212165740 cites W2087490647 @default.
• W3212165740 cites W2091053114 @default.
• W3212165740 cites W2098472712 @default.
• W3212165740 cites W2099415813 @default.
• W3212165740 cites W2106059433 @default.
• W3212165740 cites W2109532587 @default.
• W3212165740 cites W2114675993 @default.
• W3212165740 cites W2120767831 @default.
• W3212165740 cites W2121236726 @default.
• W3212165740 cites W2132066552 @default.
• W3212165740 cites W2135898905 @default.
• W3212165740 cites W2141371342 @default.
• W3212165740 cites W2146413877 @default.
• W3212165740 cites W2148875560 @default.
• W3212165740 cites W2153246785 @default.
• W3212165740 cites W2215861303 @default.
• W3212165740 cites W2227911728 @default.
• W3212165740 cites W2290466312 @default.
• W3212165740 cites W2328780360 @default.
• W3212165740 cites W2330871695 @default.
• W3212165740 cites W2800514731 @default.
• W3212165740 cites W2807127100 @default.
• W3212165740 cites W2903199417 @default.
• W3212165740 cites W2922403047 @default.
• W3212165740 cites W3016219057 @default.
• W3212165740 cites W3045367816 @default.
• W3212165740 cites W4253158066 @default.
• W3212165740 cites W990126594 @default.
• W3212165740 doi "https://doi.org/10.1124/dmd.121.000633" @default.
• W3212165740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34785568" @default.
• W3212165740 hasPublicationYear "2021" @default.
• W3212165740 type Work @default.
• W3212165740 sameAs 3212165740 @default.
• W3212165740 citedByCount "5" @default.
• W3212165740 countsByYear W32121657402022 @default.
• W3212165740 countsByYear W32121657402023 @default.
• W3212165740 crossrefType "journal-article" @default.
• W3212165740 hasAuthorship W3212165740A5016526298 @default.
• W3212165740 hasAuthorship W3212165740A5017978744 @default.
• W3212165740 hasAuthorship W3212165740A5018244700 @default.
• W3212165740 hasAuthorship W3212165740A5020229055 @default.
• W3212165740 hasAuthorship W3212165740A5035565807 @default.
• W3212165740 hasAuthorship W3212165740A5044949766 @default.
• W3212165740 hasAuthorship W3212165740A5046280891 @default.
• W3212165740 hasAuthorship W3212165740A5050632280 @default.
• W3212165740 hasAuthorship W3212165740A5056114856 @default.
• W3212165740 hasAuthorship W3212165740A5056914488 @default.
• W3212165740 hasAuthorship W3212165740A5073265550 @default.
• W3212165740 hasAuthorship W3212165740A5074564751 @default.
• W3212165740 hasAuthorship W3212165740A5078548892 @default.
• W3212165740 hasAuthorship W3212165740A5079261300 @default.
• W3212165740 hasAuthorship W3212165740A5081844561 @default.
• W3212165740 hasAuthorship W3212165740A5090813047 @default.
• W3212165740 hasBestOaLocation W32121657401 @default.
• W3212165740 hasConcept C181199279 @default.
• W3212165740 hasConcept C185592680 @default.
• W3212165740 hasConcept C2780035454 @default.

• next